Nucleic Acid Diversity in cGAS-STING Pathway Activation and Immune Dysregulation

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• The cGAS-STING pathway is a central component of innate immunity, detecting abnormal nucleic acids.
• Key molecules like cGAS, STING, IFN-β, and IL-6 can serve as disease biomarkers.

Purpose of the Study:

• To elucidate the molecular mechanisms of nucleic acid-mediated regulation of the cGAS-STING pathway.
• To explore the role of this pathway in various disease contexts.
• To highlight therapeutic strategies targeting the cGAS-STING pathway.

Main Methods:

• This review synthesizes current research on the cGAS-STING pathway.
• It analyzes the diverse mechanisms of nucleic acid activation and cellular regulation.
• It discusses therapeutic interventions targeting pathway components.

Main Results:

• The cGAS-STING pathway recognizes pathogen-associated and self-derived nucleic acids to initiate immune responses.
• Cells possess regulatory mechanisms to prevent aberrant pathway activation, including DNA restriction and signal termination.
• Therapeutic strategies focus on reducing nucleic acid accumulation or inhibiting cGAS/STING.

Conclusions:

• Understanding cGAS-STING pathway regulation is vital for developing treatments for infectious diseases, cancer, and autoimmune disorders.
• Targeting this pathway offers novel therapeutic opportunities.
• Further research into nucleic acid-mediated regulation can refine disease management strategies.